{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:03:03Z","timestamp":1787022183141,"version":"build-2736575974"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010724","name":"Health Systems Research Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010724","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Given the lack of cost-effectiveness information, continuous ambulatory peritoneal dialysis (CAPD) with icodextrin (CAPD+ICO) has not yet been included in the Universal Health Coverage (UHC) scheme. This study aimed to evaluate the cost-utility of dialysis treatments for end-stage renal disease (ESRD) patients with fluid and sodium overload, comparing CAPD+ICO and automated peritoneal dialysis (APD) against glucose-based CAPD. A Markov model was applied to evaluate lifetime costs and health outcomes from a societal perspective. Data, including transitional probabilities, direct medical and non-medical costs, and utilities, were collected from randomized controlled trials conducted across 16 hospitals in various regions of Thailand. Compared to glucose-based CAPD, the incremental cost-effectiveness ratio (ICER) for CAPD+ICO was 908,440 THB (26,082 USD) per quality-adjusted life year (QALY) gained, while APD was dominated, incurring higher costs and yielding fewer QALYs. The results indicated that glucose-based CAPD had a 90% probability of being the most cost-effective option from a societal perspective, based on Thailand\u2019s willingness-to-pay (WTP)\u00a0threshold of 160,000 THB (4,603 USD) per QALY gained. Therefore, CAPD+ICO is not considered a good value for money, requiring an additional annual budget of approximately 58 million THB (2 million USD). These findings provide important economic evaluation evidence to support policy decision-making alongside clinical effectiveness and equity considerations in guiding future UHC benefit package decisions for dialysis modalities among ESRD patients with fluid and sodium overload in Thailand.<\/jats:p>","DOI":"10.1371\/journal.pone.0335749","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:28:37Z","timestamp":1762367317000},"page":"e0335749","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Economic evaluation of dialysis treatment in end-stage renal disease patients with fluid and sodium overload: Evidence from a randomized controlled trial in Thailand"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2448-3954","authenticated-orcid":true,"given":"Sitaporn","family":"Youngkong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panida","family":"Yoopetch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montarat","family":"Thavorncharoensap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montira","family":"Assanatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9457-9823","authenticated-orcid":true,"given":"Usa","family":"Chaikledkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchai","family":"Sritippayawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"1","key":"pone.0335749.ref001","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2648.2005.03455.x","article-title":"Quality of life of patients having renal replacement therapy","volume":"51","author":"S-F Niu","year":"2005","journal-title":"J Adv Nurs"},{"issue":"2","key":"pone.0335749.ref002","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11255-007-9225-7","article-title":"Quality of life in the elderly patients on dialysis","volume":"39","author":"T Apostolou","year":"2007","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"pone.0335749.ref003","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/08860220601098862","article-title":"Quality of life in CAPD, transplant, and chronic renal failure patients with diabetes","volume":"29","author":"T Apostolou","year":"2007","journal-title":"Ren Fail"},{"issue":"2","key":"pone.0335749.ref004","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269216308101099","article-title":"Symptom burden and quality of life in end-stage renal disease: a study of 179 patients on dialysis and palliative care","volume":"23","author":"DSP Yong","year":"2009","journal-title":"Palliat Med"},{"key":"pone.0335749.ref005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.vhri.2014.01.001","article-title":"Cost-utility analysis of erythropoietin for anemia treatment in thai end-stage renal disease patients with hemodialysis","volume":"3","author":"T Thaweethamcharoen","year":"2014","journal-title":"Value Health Reg Issues"},{"issue":"10126","key":"pone.0335749.ref006","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/S0140-6736(18)30198-3","article-title":"Health systems development in Thailand: a solid platform for successful implementation of universal health coverage","volume":"391","author":"V Tangcharoensathien","year":"2018","journal-title":"Lancet"},{"issue":"10","key":"pone.0335749.ref007","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.02380218","article-title":"Biocompatible solutions and long-term changes in peritoneal solute transport","volume":"13","author":"EH Elphick","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0335749.ref008","volume-title":"Survival of end-stage renal disease patients who undergo continuous ambulatory peritoneal dialysis as the initial treatment strategy under the universal coverage of Thailand","author":"J Baosanthia","year":"2014"},{"key":"pone.0335749.ref009","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fphys.2018.01853","article-title":"Biocompatible peritoneal dialysis: the target is still way off","volume":"9","author":"M Bartosova","year":"2019","journal-title":"Front Physiol"},{"issue":"10","key":"pone.0335749.ref010","article-title":"Biocompatible dialysis fluids for peritoneal dialysis","volume":"10","author":"H Htay","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"pone.0335749.ref011","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1053\/j.ajkd.2013.11.025","article-title":"Comparative outcomes between continuous ambulatory and automated peritoneal dialysis: a narrative review","volume":"63","author":"SD Bieber","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"pone.0335749.ref012","volume-title":"Feasibility study of the inclusion of automated peritonieal dialysis and icodextrin solution for fluid overload adult chronic ESKD patients in the National Health Security System of Thailand","author":"S Sritippayawan","year":"2024"},{"key":"pone.0335749.ref013","unstructured":"Exchange-Rates.org. Thai Baht to US Dollar Spot Exchange Rates for 2023. 2023. Available from: https:\/\/www.exchange-rates.org\/exchange-rate-history\/thb-usd-2023"},{"key":"pone.0335749.ref014","volume-title":"Guideline for health technology assessment in Thailand updated edition: 2019-2021","author":"Guideline Development Working Group","year":"2021"},{"key":"pone.0335749.ref015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2147\/CEOR.S38062","article-title":"Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?","volume":"5","author":"M Thavorncharoensap","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"issue":"8","key":"pone.0335749.ref016","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/nep.12668","article-title":"Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore","volume":"21","author":"F Yang","year":"2016","journal-title":"Nephrology (Carlton)"},{"issue":"11","key":"pone.0335749.ref017","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.34067\/KID.0000000576","article-title":"Effect of time interval and frequency of hospitalization because of fluid overload on survival in peritoneal dialysis: Thailand experience","volume":"5","author":"J Thuanman","year":"2024","journal-title":"Kidney360"},{"issue":"3","key":"pone.0335749.ref018","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/089686080102100313","article-title":"A comparison of quality of life of patients on automated and continuous ambulatory peritoneal dialysis","volume":"21","author":"GA de Wit","year":"2001","journal-title":"Perit Dial Int"},{"issue":"6","key":"pone.0335749.ref019","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/089686089901900606","article-title":"A prospective, randomized multicenter study comparing APD and CAPD treatment","volume":"19","author":"S Bro","year":"1999","journal-title":"Perit Dial Int"},{"key":"pone.0335749.ref020","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.vhri.2019.10.004","article-title":"Cost-utility analysis of continuous ambulatory peritoneal dialysis and automated peritoneal dialysis for Thai patients with end-stage renal disease","volume":"21","author":"T Thaweethamcharoen","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"pone.0335749.ref021","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1186\/s12913-022-08827-0","article-title":"Economic evaluation of peritoneal dialysis and hemodialysis in Thai population with End-stage Kidney Disease","volume":"22","author":"M Assanatham","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"2","key":"pone.0335749.ref022","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017148","article-title":"Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohort","volume":"6","author":"W Van Biesen","year":"2011","journal-title":"PLoS One"},{"issue":"11","key":"pone.0335749.ref023","first-page":"1906","article-title":"Overhydration and low lean tissue index are associated with higher mortality in chronic kidney disease stage 5 patients on peritoneal dialysis","volume":"30","author":"M Jotterand","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0335749.ref024","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ki.2014.207","article-title":"The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients","volume":"86","author":"SJ Davies","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"pone.0335749.ref025","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/cer.12.10","article-title":"Using health technology assessment for informing coverage decisions in Thailand","volume":"1","author":"A Mohara","year":"2012","journal-title":"J Comp Eff Res"},{"issue":"6","key":"pone.0335749.ref026","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0266462319000321","article-title":"Health technology assessment in Thailand: institutionalization and contribution to healthcare decision making: review of literature","volume":"35","author":"P Leelahavarong","year":"2019","journal-title":"Int J Technol Assess Health Care"},{"issue":"3","key":"pone.0335749.ref027","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.semnephrol.2017.02.008","article-title":"PD First Policy: Thailand\u2019s response to the challenge of meeting the needs of patients with end-stage renal disease","volume":"37","author":"P Chuengsaman","year":"2017","journal-title":"Semin Nephrol"},{"issue":"1","key":"pone.0335749.ref028","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1524-4733.2006.00145.x","article-title":"Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand","volume":"10","author":"Y Teerawattananon","year":"2007","journal-title":"Value Health"},{"key":"pone.0335749.ref029","unstructured":"The World Bank Group. GDP per capita (current US$). 2021. [cited 2022 Dec 5]. Available from: https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=TH"},{"key":"pone.0335749.ref030","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1017\/S0266462309090709","article-title":"Historical development of health technology assessment in Thailand","volume":"25","author":"T Y","year":"2009","journal-title":"Int J Technol Assess Health Care"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T18:28:43Z","timestamp":1762367323000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335749"}},"subtitle":[],"editor":[{"given":"Teerawat","family":"Thanachayanont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":30,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335749","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]}}}